Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,720Revenue (TTM) $M197Net Margin (%)-112.3Altman Z-Score1.8
Enterprise Value $M2,739EPS (TTM) $-3.5Operating Margin %-180.3Piotroski F-Score1
P/E(ttm)--Beneish M-Score-2.6Pre-tax Margin (%)-52.3Higher ROA y-yN
Price/Book3.210-y EBITDA Growth Rate %--Quick Ratio3.3Cash flow > EarningsN
Price/Sales13.55-y EBITDA Growth Rate %--Current Ratio3.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-533.1ROA % (ttm)-11.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-27.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M70.6ROIC % (ttm)-36.7Gross Margin Increase y-yN

Gurus Latest Trades with MDCO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MDCOFirst Eagle Investment 2016-06-30 Buy 0.05%$31.77 - $38.48
($35.2)
$ 38.5510%New holding555,099
MDCOVanguard Health Care Fund 2015-03-31 Add0.01%$24.32 - $31.29
($28.09)
$ 38.5537%Add 1.88%5,564,220
MDCOVanguard Health Care Fund 2014-12-31 Add0.04%$20.36 - $27.96
($24.81)
$ 38.5555%Add 14.67%5,461,430
MDCOJoel Greenblatt 2014-12-31 Sold Out -0.01%$20.36 - $27.96
($24.83)
$ 38.5555%Sold Out0
MDCOJoel Greenblatt 2014-09-30 Reduce-0.06%$22.95 - $29.64
($25.38)
$ 38.5552%Reduce -87.68%24,009
MDCOGeorge Soros 2014-09-30 Sold Out -0.02%$22.95 - $29.64
($25.38)
$ 38.5552%Sold Out0
MDCOVanguard Health Care Fund 2014-09-30 Add$22.32 - $29.64
($25.4)
$ 38.5552%Add 1.33%4,762,730
MDCOJoel Greenblatt 2014-06-30 Buy 0.07%$24.02 - $29.57
($26.67)
$ 38.5545%New holding194,954
MDCOGeorge Soros 2014-06-30 Buy 0.02%$24.02 - $29.57
($26.67)
$ 38.5545%New holding75,000
MDCOGeorge Soros 2014-03-31 Sold Out -0.02%$27.9 - $40.39
($33.35)
$ 38.5516%Sold Out0
MDCOJoel Greenblatt 2014-03-31 Sold Out -0.01%$27.9 - $40.39
($33.35)
$ 38.5516%Sold Out0
MDCOVanguard Health Care Fund 2014-03-31 Add0.01%$27.9 - $40.39
($33.09)
$ 38.5517%Add 2.20%4,700,058
MDCOGeorge Soros 2013-12-31 Reduce-0.07%$31.48 - $38.91
($35.74)
$ 38.558%Reduce -80.00%50,000
MDCOVanguard Health Care Fund 2013-12-31 Add0.04%$31.48 - $38.91
($35.78)
$ 38.558%Add 8.20%4,599,069
MDCOJoel Greenblatt 2013-12-31 Buy 0.01%$31.48 - $38.91
($35.74)
$ 38.558%New holding13,990
MDCOVanguard Health Care Fund 2013-09-30 Add0.33%$29.68 - $34.54
($31.83)
$ 38.5521%Add 219.22%4,250,415
MDCOGeorge Soros 2013-09-30 Add0.04%$29.68 - $34.54
($31.83)
$ 38.5521%Add 66.67%250,000
MDCOVanguard Health Care Fund 2013-06-30 Add0.1%$30.76 - $37.1
($33.46)
$ 38.5515%Add 181.56%1,331,500
MDCOGeorge Soros 2013-06-30 Add0.02%$30.76 - $37.1
($33.46)
$ 38.5515%Add 57.89%150,000
MDCOVanguard Health Care Fund 2013-03-31 Buy 0.06%$23.97 - $33.41
($30.53)
$ 38.5526%New holding472,900
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MDCO is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MDCO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MEANWELL CLIVECEO 2016-08-24Sell20,000$40-3.63view
Shigeta HiroakiDirector 2016-07-11Sell3,849$38.50.13view
Shigeta HiroakiDirector 2016-06-13Sell20,000$36.764.87view
Shigeta HiroakiDirector 2016-06-13Sell20,000$36.764.87view
Cox Christopher TEVP & Chief Corp. Dev. Officer 2016-06-10Buy45,985$37.91.72view
Cox Christopher TEVP & Chief Corp. Dev. Officer 2016-06-07Buy53,340$37.552.66view
Savage Robert G.Director 2016-05-24Sell10,000$36.954.33view
Spigelman Melvin KDirector 2016-05-24Sell15,000$374.19view
MEANWELL CLIVECEO 2016-05-16Sell10,000$3510.14view
CROUSE WILLIAMDirector 2016-05-16Sell15,000$35.159.67view

Quarterly/Annual Reports about MDCO:

News about MDCO:

Articles On GuruFocus.com
Netflix Profit Above Consensus, Panera Bread Boosts Buyback Plan, Medicines Co Cangrelor Well-Recomm Apr 16 2015 
Chuck Royce Buys Stifel Financial, Tidewater, Alamos, Sells Kennametal, Gardner Denver, Gartner Apr 25 2013 
Weekly CFO Sells Highlight: BK, MDCO, EBAY, MS, PHMD Jan 27 2013 
Weekly CFO Sells Highlight: MDCO, SIG, VCI, PHMD, SNPS Jan 21 2013 
George Soros' Top Buys in the Last Quarter Dec 23 2011 
George Soros Buys Amazon.com Inc., Motorola Solutions, Sandisk, Sells Ralph Lauren, Dendreon, Lawson Nov 15 2011 
Medicines Company (MDCO) Chairman & CEO Clive Meanwell sells 100,000 Shares Mar 01 2011 
Medicines Company Reports Operating Results (10-Q) Nov 09 2010 
Medicines Company Reports Operating Results (10-Q) May 10 2010 
Medicines Company (MDCO) Chairman & CEO Clive Meanwell sells 181,500 Shares May 04 2010 

More From Other Websites
The Medicines Co. Offers Update on Dyslipidemia Programs Aug 31 2016
The Medicines Company Provides Update on Dyslipidemia Programs Aug 30 2016
Medicines Co. shares drop as early drug trial results not promising Aug 30 2016
4:31 pm The Medicines Co updates on its clinical dyslipidemia research program for MDCO-216;... Aug 30 2016
The Medicines Company Provides Update on Dyslipidemia Programs Aug 30 2016
ETF’s with exposure to The Medicines Co. : August 30, 2016 Aug 30 2016
5 Trade Ideas for Monday: Apache, E*TRADE, Medicines Company, MGP Ingredients and PNC Aug 28 2016
MEDICINES CO /DE Files SEC form 8-K, Change in Directors or Principal Officers Aug 18 2016
Mallinckrodt (MNK) to Buy Stratatech for Undisclosed Value Aug 12 2016
MEDICINES CO /DE Financials Aug 11 2016
ETF’s with exposure to The Medicines Co. : August 11, 2016 Aug 11 2016
The Medicines Co. :MDCO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 8, 2016 Aug 08 2016
MEDICINES CO /DE Files SEC form 10-Q, Quarterly Report Aug 05 2016
Come Take Your Medicine (Company) Aug 04 2016
Edited Transcript of MDCO earnings conference call or presentation 27-Jul-16 12:30pm GMT Jul 27 2016
Mallinckrodt (MNK) Q3 Earnings: Will the Stock Surprise? Jul 27 2016
The Medicines Company Reports Second-Quarter 2016 Business and Financial Results Jul 27 2016
Medicines Co. posts 2Q profit Jul 27 2016
Medicines Co. posts 2Q profit Jul 27 2016
Q2 2016 Medicines Co Earnings Release - Before Market Open Jul 27 2016
MEDICINES CO /DE Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 27 2016
The Medicines Company Reports Second-Quarter 2016 Business and Financial Results Jul 27 2016
5 Drug Stocks' Earnings on Jul 27: AMGN, VRTX & More Jul 26 2016
Call buyers targeting Medicines Company Jul 20 2016
The Medicines Company to Announce Second Quarter Financial Results on July 27, 2016 Jul 18 2016
Federal Circuit Rules for The Medicines Company in Angiomax® (bivalirudin) Patent Litigation Jul 12 2016
The Medicines Company Announces Positive Top- Line Results for Phase 3 TANGO 1 Clinical Trial of... Jun 27 2016
The Medicines Company Completes Divestiture of its Non-Core Cardiovascular Assets to Chiesi Jun 21 2016
The Medicines Company Announces Initiation of Phase II Study for its Investigational Anesthetic,... Jun 14 2016
The Medicines Company Prices $350 Million of Convertible Notes Jun 06 2016
The Medicines Company Completes Patient Enrollment for ORION-1 Study of PCSK9si Jun 02 2016
New incentives needed to develop antibiotics to fight superbugs May 29 2016
New incentives needed to develop antibiotics to fight superbugs May 27 2016
The Medicines Company Announces Completion of Patient Enrollment in Phase 3 TANGO 1 Study of... May 26 2016
The Medicines Company to Present at Two Upcoming Investor Conferences May 25 2016
The Medicines Company Appoints Tony Kingsley as President and Chief Operating Officer May 16 2016
Deals of the day- Mergers and acquisitions May 09 2016
The Medicines Company Reports First-Quarter 2016 Business and Financial Results May 09 2016
The Medicines Company Agrees to Divest Non-Core Cardiovascular Assets to Chiesi Farmaceutici S.p.A. May 09 2016
Medicines Co. reports 1Q loss May 09 2016
The Medicines Company to Present at Bank of America Merrill Lynch 2016 Health Care Conference May 02 2016
The Medicines Company to Announce First Quarter Financial Results on May 9, 2016 Apr 26 2016
The Medicines Company Announces Participation at 2016 American College of Cardiology (ACC)... Mar 28 2016
Medicines Co. reports 4Q loss Feb 17 2016
The Medicines Company Advances Clinical Development of Investigational First-in-Class PCSK9... Jan 11 2016
The Medicines Company to Participate in J.P. Morgan 34th Annual Healthcare Conference Jan 04 2016
The Medicines Company Agrees to Divest its Hemostasis Portfolio to Mallinckrodt plc Dec 18 2015
The Medicines Company Announces Investigational Lipid Modulating Agent, MDCO-216, Phase 1 Data... Dec 14 2015
Medicines Co. reports 3Q loss Nov 03 2015
Analysis from CHAMPION PHOENIX Trial Highlight the Efficacy of Cangrelor among Patients undergoing... Sep 01 2015
Medicines shares surge on upbeat cholesterol drug study Aug 31 2015
Alnylam, Medicines cholesterol drug lasts months after one shot Aug 30 2015
Medicines Co. reports 2Q loss Jul 29 2015
Medicines Co. misses 1Q revenue forecasts May 05 2015
BUZZ-U.S. STOCKS ON THE MOVE-LinkedIn, Tesla, Lloyds, CVS Health May 01 2015
Medicines Co. slumps as company forecasts big sales decline Apr 09 2015
US STOCKS-Wall St ends up on energy rebound; early earnings weak Apr 09 2015
Medicines Co. reports 4Q loss Feb 18 2015
Medicines Co. beats 3Q earnings expectations Oct 22 2014

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)